PCOS is associated with increased risk of which cardiovascular/metabolic conditions?

PCOS is associated with increased risk of which cardiovascular/metabolic conditions?

• A. Hypertension, dyslipidemia, and metabolic syndrome
• B. PCOS reduces risk of metabolic syndrome
• C. PCOS has no impact on cardiovascular risk
• D. PCOS prevents dyslipidemia

Answer: (A)

Polycystic ovary syndrome is linked to higher risk of cardiometabolic problems because insulin resistance and often increased central adiposity drive a cluster of abnormalities. Insulin resistance leads to compensatory hyperinsulinemia, which promotes higher triglycerides and lower HDL cholesterol (dyslipidemia) and contributes to higher blood pressure over time. Central obesity and impaired glucose tolerance further push the development of metabolic syndrome, a grouping that includes hypertension, dyslipidemia, and abnormal glucose metabolism. This combination raises long-term cardiovascular risk compared with those without PCOS. The other statements contradict the evidence: PCOS does not lower metabolic syndrome risk, it does impact cardiovascular risk, and it does not prevent dyslipidemia.

Polycystic ovary syndrome is linked to higher risk of cardiometabolic problems because insulin resistance and often increased central adiposity drive a cluster of abnormalities. Insulin resistance leads to compensatory hyperinsulinemia, which promotes higher triglycerides and lower HDL cholesterol (dyslipidemia) and contributes to higher blood pressure over time. Central obesity and impaired glucose tolerance further push the development of metabolic syndrome, a grouping that includes hypertension, dyslipidemia, and abnormal glucose metabolism. This combination raises long-term cardiovascular risk compared with those without PCOS. The other statements contradict the evidence: PCOS does not lower metabolic syndrome risk, it does impact cardiovascular risk, and it does not prevent dyslipidemia.